Concepedia

Helen Lavender

HL

Statistics

Publications

5

Citations

225

H-Index

5

Active since

2011

Affiliations

Pfizer (United Kingdom)(Current)

Children's Hospital of Philadelphia

Pfizer (United States)

Helen Lavender is an author at Pfizer (United Kingdom) specializing in drug discovery, medicine, and molecular biology.

Top concepts

Publications per year

2011–2023

5

Publications

5

Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action

Paul Targett‐Adams, Emily J. S. Graham, Jenny Middleton et al. · Journal of Virology · 2011 · 119 citations

, , +20

Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model

David Suhy, Shih-Chu Kao, Tin K. Mao et al. · Molecular Therapy · 2012 · 58 citations · Full text

Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision

Hubert Denise, Sterghios Moschos, Ben S. Sidders et al. · Molecular Therapy — Nucleic Acids · 2014 · 24 citations · Full text

<i>In Vitro</i> Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy

Helen Lavender, Kevin Brady, Frances Burden et al. · Antimicrobial Agents and Chemotherapy · 2011 · 14 citations · Full text

, , +17

Selection of optimised ligands by fluorescence-activated bead sorting

Alexandra R. Paul, Mario Falsaperna, Helen Lavender et al. · Chemical Science · 2023 · 10 citations · Full text

, , +15

1–5 of 5